<DOC>
	<DOCNO>NCT00293644</DOCNO>
	<brief_summary>The purpose study determine whether pre-emptive use delay release combination pyridoxine hydrochloride doxylamine succinate ( Diclectin® ) , eruption symptom Nausea vomit pregnancy hyperemesis gravidarum , reduce incidence severe form syndrome/HG .</brief_summary>
	<brief_title>Pre-emptive Treatment Severe Nausea Vomiting Pregnancy</brief_title>
	<detailed_description>Nausea vomit pregnancy ( NVP ) affect 80 % pregnant woman , persists throughout pregnancy 20 % woman . 1 % -3 % pregnant woman experience extreme form call hyperemesis gravidarum ( HG ) , describe intractable vomiting associate weight loss 5 % pre-pregnancy weight , dehydration electrolyte imbalance may lead hospitalization . Treatment involve administration antiemetic NVP occurs . Although wide evidence fetal safety several antiemetic medication , woman health professional often reluctant use antiemetic due heighten misperception teratogenic risk . Diclectin® prescription drug Canada specifically indicate treatment NVP . Our preliminary research show Diclectin® effective pre-emptive treatment NVP symptom woman experience severe NVP/HG previous pregnancy . This study evaluate effectiveness Diclectin pre-emptive treatment NVP HG randomize control trial . In Pre-emptive Treatment Group , soon patient becomes aware present pregnancy , NVP start , take initial Diclectin® dose , follow standard dose match symptom NVP develop . In Standard Treatment Group woman take Diclectin® appearance symptom . A natural history control group also include . This study determine whether pre-emptive use Diclectin reduce incidence severe form syndrome/HG .</detailed_description>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Hyperemesis Gravidarum</mesh_term>
	<mesh_term>Dicyclomine , doxylamine , pyridoxine drug combination</mesh_term>
	<mesh_term>Doxylamine</mesh_term>
	<mesh_term>Dicyclomine</mesh_term>
	<mesh_term>Pyridoxine</mesh_term>
	<criteria>Pregnancy le 9 week gestation symptom NVP Not pregnant Include woman severe NVP/HG previous pregnancy regardless outcome Severe NVP/HG previous pregnancy verbally confirm initial recruitment intake questionnaire previous pregnancy history NVP/HG section ( duration , severity , treatment , hospitalisation ) Verbally agree participate study send back rhe informed consent form Sufficient French English language skill understand questionnaire assessment material Women agree take Diclectin® Women enrol consecutive pregnancy , study still ongoing Women refuse participate study send back sign consent form Women insufficient French English language skill understand questionnaire assessment material Women first pregnancy hav n't suffer severe NVP/HG previous pregnancy Gestational age beyond 9w+0d week pregnancy Pregnant woman already suffer symptom NVP Pregnant woman know hypersensitivity Diclectin® Women agree take Diclectin® Women suffer symptom pyelonephritis , thyrotoxicosis , gestational trophoblastic neoplasia Pregnant woman less 18 year age</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Pregnancy Complications</keyword>
	<keyword>Hyperemesis Gravidarum</keyword>
	<keyword>Diclectin</keyword>
	<keyword>doxylamine succinate</keyword>
	<keyword>pyridoxine hydrochloride</keyword>
</DOC>